Andrea,

the Regulation has been narrowed allot because of the reaction of the 
pharmaceutical market 
basically what's needed is 3 things
1.Audit trail of changes,
2.elcrronic signatures
3.and security (passwords) which there basically

1.SSA is recommending a certain 3rd party product for the auditing trail 
which is quit easy to implement
2.they had  released the ES module on version 8 and above (if you really 
want you can get them to "downgrade" the fix to an earlier version- that's 
what we are planning on doing)

regarding reports on the Audit trail - you have to do it yourself 

Danny Monselise ,    ClayPark Labs 
--------------------------------------------------------





Andrea Garzia <andrea.garzia@xxxxxxxxxxxxx>
Sent by: bpcs-l-bounces@xxxxxxxxxxxx
06/11/2004 09:47 AM
Please respond to "SSA's BPCS ERP System"
 
        To:     "SSA's BPCS ERP System" <bpcs-l@xxxxxxxxxxxx>
        cc: 
        Subject:        21 CFR Part 11 requirements


Does anyone knows if SSA is going to follow with its Iseries products
reporting capabilities matching
21CFR11 requirements or there are any software vendor providing customized
software on 21CFR11 for BPCS products?

Thanks to all upcoming responses

Andrea Garzia
Business Consultant

_______________________________________________
This is the SSA's BPCS ERP System (BPCS-L) mailing list
To post a message email: BPCS-L@xxxxxxxxxxxx
To subscribe, unsubscribe, or change list options,
visit: http://lists.midrange.com/mailman/listinfo/bpcs-l
or email: BPCS-L-request@xxxxxxxxxxxx
Before posting, please take a moment to review the archives
at http://archive.midrange.com/bpcs-l.


This thread ...

Replies:

Follow On AppleNews
Return to Archive home page | Return to MIDRANGE.COM home page

This mailing list archive is Copyright 1997-2019 by midrange.com and David Gibbs as a compilation work. Use of the archive is restricted to research of a business or technical nature. Any other uses are prohibited. Full details are available on our policy page. If you have questions about this, please contact [javascript protected email address].